Skip to main content
MDGL
NASDAQ Life Sciences

Madrigal Secures Exclusive Global License for Aro-Pnpla3 from Arrowhead, Committing Up to $1 Billion in Milestones

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$517
Mkt Cap
$11.898B
52W Low
$265
52W High
$615
52W Position info
95% above low
Off High info
16% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

MDGL sits 95% above its 52-week low of $265.

Summary

Madrigal Pharmaceuticals announced an exclusive global licensing agreement for Aro-Pnpla3 from Arrowhead. The deal involves a $25 million upfront payment to Arrowhead, with potential milestone payments totaling up to $975 million, in addition to royalties. This agreement strategically expands Madrigal's development pipeline, aligning with the company's stated goal in its recent 10-K to expand its MASH pipeline through new licensing agreements. While the upfront cost is relatively modest, the potential $975 million in milestones represents a significant long-term investment in a new asset. Traders will be watching for further updates on the clinical development of Aro-Pnpla3 and any future financial implications.

At the time of this announcement, MDGL was trading at $517.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $11.9B. The 52-week trading range was $265.00 to $615.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

MDGL - Latest Insights

MDGL
Nov 06, 2026, 5:30 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $399.93
Real-time Price: $395.00 info
Change: -$4.93 (-1%) info
Market Cap: $9.247B info
MDGL
Nov 05, 2026, 10:35 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $408.99
Real-time Price: $395.00 info
Change: -$13.99 (-3%) info
Market Cap: $9.247B info
MDGL
Nov 03, 2026, 9:10 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $428.01
Real-time Price: $395.00 info
Change: -$33.01 (-8%) info
Market Cap: $9.247B info
MDGL
Nov 03, 2026, 8:08 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $477.00
Real-time Price: $395.00 info
Change: -$82.00 (-17%) info
Market Cap: $9.247B info
MDGL
Nov 03, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $431.16
Real-time Price: $395.00 info
Change: -$36.15 (-8%) info
Market Cap: $9.247B info